This page reprints a manufacturer label. Everything below in quotation marks is copied from Lidocaine Hydrochloride Injectable-2%, published by FDA and retrieved on 2026-09-16. Nothing has been added, reworded or left out of the sections shown. It is the manufacturer’s label, reproduced as published.
This page reprints the FDA label for Lidocaine Hydrochloride Injectable-2% by Clipper Distributing Company, LLC, a lidocaine product labelled for dogs and cats. The sections below are copied from that label without change, with the set id and the date it was retrieved from DailyMed. 6 other stored labels carry the same active ingredient and are listed at the end.
The label
Product: Lidocaine Hydrochloride Injectable-2%. Manufacturer: Clipper Distributing Company, LLC. FDA Structured Product Label set id 97e3c22e-3bc8-42b2-9214-05228f407be9. Label effective 2013-06-17. Retrieved 2026-09-16 from the DailyMed animal label release, and readable on DailyMed.
Indications
Lidocaine is a potent local anesthetic for producing epidural and nerve conduction anesthesia.
Dosage and Administration
Epidural Cattle and Horses - 5 to 15 mL Dogs and Cats - 1 mL per 10 pounds of body weight. Nerve Block Cattle and Horses - 5 to 20 mL Infiltration Dilute to 0.5% concentration (1 mL of 2% solution diluted with 3 mL of sterile water = 4 mL of a 0.5% solution) COMPOSITION Each mL of sterile aqueous solution contains: Lidocaine Hydrochloride........................2.0% Propylene Glycol..................................5.2% Sodium Chloride...................................0.5% Sodium Lactate....................................0.5% with Methylparaben 0.15%, Sodium Metabisulfite 0.10%, Propylparaben 0.03%, and Disodium Edetate 0.001% as preservatives. Store at controlled room temperature between 15 o and 30 o C (59 o -86 o F) TAKE TIME OBSERVE LABEL DIRECTIONS Lidocaine Inj-13 Label
Contraindications
Lidocaine is contraindicated in animals with a known hypersensitivity to the drug.
Precautions
Lidocaine is usually well tolerated. Nevertheless, as with all local anesthetics, untoward effects may occur due to hypersensitivity, faulty technique, overdosage and inadvertent intravascular or subarachnoid injection. In case of respiratory arrest, immediate resuscitation with oxygen is indicated.
Other labels for this ingredient
These labels are also stored for the same active ingredient. They are not identical to the one reprinted above, and each is listed by product and set id rather than merged with it.
- Lidocaine Hydrochloride 2%, VetTek. Set id cc93b0a3-f852-43a6-a1fd-bcba1b0b34af.
- Lidocaine 2%, Covetrus North America. Set id 5aeff72e-f306-4143-ab42-f8a0883e4138.
- LIDOCAINE INJECTION Local Anesthetic, Aspen Veterinary Resources, Ltd.. Set id b03abdc6-9c01-4ae9-b5f2-22ba6d07be37.
- LIDOCAINE INJECTABLE 2% LOCAL ANESTHETIC, Vedco, Inc.. Set id 2393804d-421a-423a-9d49-2a18cd102fe3.
- LIDOCAINE INJECTABLE LOCAL ANESTHETIC, Sparhawk Laboratories, Inc.. Set id cda35338-7f86-4d38-a016-a0c35a05a234.
- Lidocaine 2% Injection Local Anesthetic, MWI/VetOne. Set id 84d4dc99-daaa-41e5-9da9-25c7922e285f.
FDA adverse event reports
The FDA Center for Veterinary Medicine publishes the adverse event reports it receives through openFDA. The counts below are the reports naming lidocaine as an active ingredient for each species this label names, as returned on 2026-09-16, coded by the VeDDRA reaction term the reporter chose. Reactions are counted per report, so one report can appear under several terms.
These are counts, not rates. Reporting is voluntary, the number of animals treated is not known, and a widely used product accumulates reports for that reason alone. A report records that an event followed a dose; it does not establish that the product caused it. The counts say nothing about how one product compares with another.
Dogs: 318 reports
| VeDDRA reaction term | Reports |
|---|---|
| Vomiting | 65 |
| Other abnormal test result NOS | 59 |
| Death | 48 |
| Lethargy (see also Central nervous system depression in 'Neurological') | 45 |
| Death by euthanasia | 41 |
| Anorexia | 38 |
| Diarrhoea | 36 |
| Tachycardia | 32 |
| Decreased appetite | 28 |
| Elevated alanine aminotransferase (ALT) | 27 |
| Cardiac arrest | 26 |
| Pale mucous membrane | 26 |
| Lack of efficacy - NOS | 25 |
| Bradycardia | 22 |
| Lethargy (see also Central nervous system depression in Neurological) | 22 |
Outcome as recorded by the reporter: Recovered/Normal 96; Ongoing 79; Died 53; Outcome Unknown 49; Euthanized 38; Recovered with Sequela 2.
Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.
Cats: 176 reports
| VeDDRA reaction term | Reports |
|---|---|
| Behavioural disorder NOS | 27 |
| Death | 23 |
| Not eating | 22 |
| Hyperthermia | 17 |
| Lethargy (see also Central nervous system depression in 'Neurological') | 17 |
| Other abnormal test result NOS | 15 |
| Anorexia | 14 |
| Dilated pupils | 14 |
| Dysphoria | 14 |
| Agitation | 13 |
| Weight loss | 13 |
| Death by euthanasia | 12 |
| Hyperactivity | 11 |
| Ataxia | 10 |
| Dehydration | 10 |
Outcome as recorded by the reporter: Ongoing 58; Recovered/Normal 51; Outcome Unknown 31; Died 25; Euthanized 11; Recovered with Sequela 1.
Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.
Sources
- Lidocaine Hydrochloride Injectable-2%FDA · retrieved 2026-09-16
“Epidural Cattle and Horses - 5 to 15 mL Dogs and Cats - 1 mL per 10 pounds of body weight.” (Dosage and Administration)
- openFDA Animal and Veterinary Adverse Event ReportsFDA · retrieved 2026-09-16
Related
From Glarda
The note drafted from the consult, with the reference you just read sitting beside it in the shape your record already expects.